Navigation Links
ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing
Date:8/23/2009

irst half of 2010, and to conduct a combined phase II/III pivotal study in various surgical indications.

About ProFibrix

ProFibrix (http://www.ProFibrix.com) was founded in 2004 and is headquartered in Leiden, The Netherlands, with a subsidiary in Seattle, WA, USA The company leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting and tissue healing. ProFibrix is led by a team with extensive commercial, clinical and scientific experience in the hemostasis field.

About Gilde Healthcare Partners

Gilde Healthcare Partners (http://www.gildehealthcare.nl) founded in 2000 is headquartered in Utrecht, the Netherlands with representatives in London and Madrid. Gilde Healthcare Partners has over EUR 275 million under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and enabling technologies. Gilde is a successful builder of healthcare businesses across Europe. By investing in companies with clear achievable business models, Gilde has used its financial resources and network to create significant value for both its investors and the entrepreneurs it backs. Companies that Gilde Healthcare Partners has proactively supported span all aspects of healthcare and include Ablynx (Belgium), Acacia Pharma (UK), Agendia (Netherlands), AMT (Netherlands), Ascendis Pharma (Denmark), Chroma Therapeutics (UK), Conatus (US), Flowcardia (US), Glycart (Switzerland), Santaris Pharma (Denmark) and Symphogen (Denmark). For a full list of Gilde's portfolio companies please visit h
'/>"/>

SOURCE ProFibrix B.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Enobia Raises US$50M from Current Investors in Series C Financing
2. TSH Testing Raises Awareness of Importance of Thyroid Health
3. NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
4. Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
5. Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
6. Americans United for Life: Obamas Disbanding Bioethics Council Raises Troubling Questions
7. Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million
8. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
9. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
10. BioVex Raises $40 Million in First Close of Series F Financing
11. Moodys Raises Boston Scientifics Rating Outlook to Stable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 ... today announced its financial results for the second ...  sales grew nearly 300% as compared to the ... first launched," said Roger Jeffs, Ph.D., United Therapeutics, ... Orenitram sales was due to an increase in ...
(Date:7/28/2015)... Israel , July 28, 2015 /PRNewswire/ ... regenerative medicine company utilizing its proprietary plant-based rhCollagen ... Shomrat Shurtz has been appointed Senior Director of ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) , ... experience in marketing, regulatory and business strategy. Prior ...
(Date:7/28/2015)... July 28, 2015  Faced with increasing challenges ... palliative rather than symptomatic, the global healthcare industry ... therapies capable of curing or significantly changing the ... to look towards regenerative medicine as a viable ... paradigm in human health with the potential to ...
(Date:7/27/2015)... , July 27, 2015  Amgen (NASDAQ: ... second quarter financial results on Thursday, July 30, 2015, ... announcement will be followed by a conference call with ... the call from Amgen will be Robert A. ... members of Amgen,s senior management team. Live ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5Amgen Announces Webcast of 2015 Second Quarter Financial Results 2
... have invented a new technology to deposit "nanostructure films" on ... eyeglasses that cost less and work better. Ultimately, the ... efficiently produce energy. The films reduce the reflectance of ... light, reduce glare and also reduce exposure to ultraviolet light. ...
... In finally answering an elusive scientific question, researchers ... National Laboratory (Berkeley Lab) have shown that the ... phase and its spatial arrangement in correlated electron ... much attention now because they can display properties ...
... , , , ... SNSS ) reported today that it received a letter, ... of The NASDAQ Stock Market notifying Sunesis that it does not ... on The NASDAQ Capital Market set forth in NASDAQ Listing Rule ...
Cached Biology Technology:New nanostructure technology provides advances in eyeglass, solar energy performance 2Strain on nanocrystals could yield colossal results 2Strain on nanocrystals could yield colossal results 3Sunesis Pharmaceuticals Receives NASDAQ Notification 2Sunesis Pharmaceuticals Receives NASDAQ Notification 3
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... corals and adding stress to Caribbean coral reefs, which ... change, coral diseases, hurricanes, pollution, and overfishing. Restoring threatened ... pressure off the other corals, according to a new ... . The small, belligerently territorial, threespot damselfish kill ...
... May 26, 2010 UC Irvine scientists have created ... the first three-dimensional tissue structure to be made from ... toward the development of transplant-ready retinas to treat eye ... affect millions. "We made a complex structure consisting ...
... Studying whole microbial communities rather than individual micro-organisms could ... to climate change or pollution, says Dr Jack Gilbert writing ... Marine microbes are responsible for 99% of the cycling ... world,s primary productivity. "Given the vital role of ocean microbes ...
Cached Biology News:Distressed damsels stress coral reefs 2UCI researchers create retina from human embryonic stem cells 2Microbes answer more questions collectively 2
PURA Immunogen: PURA (NP_005850, 183 a.a. ~ 293 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Goat polyclonal to Glucose Dehydrogenase ( Abpromise for all tested applications). Antigen: Glucose Dehydrogenase (Bacillus species)...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
Amyloid stain....
Biology Products: